Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1

Y Deng1, J Liu, G Han

  • 1Department of Dermatology, University of Colorado, Denver, Aurora, CO 80045, USA.

Oncogene
|September 7, 2010
PubMed

Insights

C-terminal binding protein 1 (CtBP1) represses the tumor suppressor Brca1 in head and neck cancers. Blocking CtBP1 activity with antioxidants may offer a new therapeutic strategy for head and neck squamous cell carcinomas (HNSCCs).

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Metabolic Regulation

Background:

  • C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor that often represses tumor suppressor genes.
  • Brca1 downregulation is an early event in head and neck squamous cell carcinomas (HNSCCs).

Purpose of the Study:

  • To investigate if CtBP1 affects Brca1 expression in head and neck tissue.
  • To elucidate the mechanism of CtBP1-mediated Brca1 repression and its potential as a therapeutic target.

Main Methods:

  • Analysis of CtBP1 binding to the Brca1 promoter using molecular techniques.
  • Assessment of CtBP1 recruitment dependency on NADH levels and hypoxia.
  • Immunostaining of human HNSCC tissue arrays.
  • Pharmacological inhibition of CtBP1 activity using Tempol.

Main Results:

  • CtBP1 represses Brca1 transcription by binding to the E2F4 site on the Brca1 promoter.
  • CtBP1 recruitment to the Brca1 promoter is redox-dependent, increasing with high NADH levels under hypoxia.
  • Nuclear CtBP1 accumulation correlates with Brca1 downregulation in HNSCC lesions.
  • Tempol treatment relieved CtBP1-mediated repression, increasing Brca1 expression and DNA repair in HNSCC cells.

Conclusions:

  • CtBP1 acts as a metabolic switch, linking tumor metabolism to tumor suppressor expression in HNSCC.
  • Blocking NADH-dependent CtBP1 activity presents a potential chemo-preventative or therapeutic strategy for HNSCC.
  • Findings provide insights into the early stages of HNSCC carcinogenesis and suggest novel therapeutic avenues.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...